Lorraine Tafra

3.4k total citations
77 papers, 2.2k citations indexed

About

Lorraine Tafra is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Lorraine Tafra has authored 77 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cancer Research, 35 papers in Surgery and 32 papers in Pathology and Forensic Medicine. Recurrent topics in Lorraine Tafra's work include Breast Cancer Treatment Studies (48 papers), Breast Lesions and Carcinomas (28 papers) and Breast Implant and Reconstruction (23 papers). Lorraine Tafra is often cited by papers focused on Breast Cancer Treatment Studies (48 papers), Breast Lesions and Carcinomas (28 papers) and Breast Implant and Reconstruction (23 papers). Lorraine Tafra collaborates with scholars based in United States, Switzerland and India. Lorraine Tafra's co-authors include Kathryn M. Verbanac, Donald R. Lannin, Martin Rosman, Kelly M. McMasters, Pat W. Whitworth, Michael J. Edwards, Kenneth P. Ramming, Melvin Swanson, Donald L. Morton and Leslie A. Wanek and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lorraine Tafra

72 papers receiving 2.2k citations

Peers

Countries citing papers authored by Lorraine Tafra

Since Specialization

Citations

This map shows the geographic impact of Lorraine Tafra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Tafra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Tafra more than expected).

Fields of papers citing papers by Lorraine Tafra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Tafra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Tafra. The network helps show where Lorraine Tafra may publish in the future.

Co-authorship network of co-authors of Lorraine Tafra

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Tafra. A scholar is included among the top collaborators of Lorraine Tafra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Tafra. Lorraine Tafra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions 2025 ·JAMA Surgery ·Laura H. Rosenberger, R. L. White, Lorraine Tafra, Judy C. Boughey, Nathalie Johnson, Harvey I. Pass, Susan K. Boolbol, (unknown), Yiming Gao, Katharine Yao	1
2	Can Axillary Ultrasound Identify Node Positive Patients Who can Avoid an Axillary Dissection After Neoadjuvant Chemotherapy? 2023 ·Journal of Surgical Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Martin Rosman, Lorraine Tafra, Rubie Sue Jackson	1
3	The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy? 2021 ·Clinical Breast Cancer ·Elaine Lee, (unknown), (unknown), (unknown), Martin Rosman, (unknown), (unknown), Lorraine Tafra, Rubie Sue Jackson	4
4	Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers 2021 ·Hematology/Oncology and Stem Cell Therapy ·Udai S. Sibia, (unknown), (unknown), Martin Rosman, (unknown), Lorraine Tafra, Rubie Sue Jackson	2
5	Combined pathologic‐genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay 2018 ·Annals of Oncology ·Michele M. Gage, (unknown), (unknown), T. Fujii, Fanny Le Du, Akshara Singareeka Raghavendra, A. K. Sinha, José Rodrigo Espinosa Fernández, (unknown), Naoto T. Ueno, Lorraine Tafra, Robert S. Jackson	7
6	ASBRS Great Debate: Sentinel Node Biopsy in Patients Over 70 Years of Age 2018 ·Annals of Surgical Oncology ·Sarah L. Blair, Catherine Tsai, Lorraine Tafra	7
7	Treatment delays from transfers of care and their impact on breast cancer quality measures 2018 ·Breast Cancer Research and Treatment ·Richard J. Bleicher, Cecilia Chang, Chihsiung E. Wang, Lori J. Goldstein, (unknown), Meena S. Moran, (unknown), (unknown), David P. Winchester, Lorraine Tafra, Katharine Yao	30
8	Prospective Study Comparing Surgeons’ Pain and Fatigue Associated with Nipple-Sparing versus Skin-Sparing Mastectomy 2017 ·Annals of Surgical Oncology ·Rubie Sue Jackson, T. A. B. Sanders, Adrian Park, R. Buras, (unknown), (unknown), (unknown), Martin Rosman, Luther H. Holton, Devinder Singh, (unknown), Lorraine Tafra	16
9	A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay 2015 ·Clinical Breast Cancer ·Michele M. Gage, Martin Rosman, (unknown), (unknown), Hyun‐Seok Kim, Leslie Cope, Christopher B. Umbricht, Antonio C. Wolff, Lorraine Tafra	43
10	Long-Term Follow-up Study of a Prospective Multicenter Sentinel Node Trial: Molecular Detection of Breast Cancer Sentinel Node Metastases 2010 ·Annals of Surgical Oncology ·(unknown), Kathryn M. Verbanac, (unknown), (unknown), Jianfen Lu, Kevin O’Brien, Martin Rosman, Lorraine Tafra	15
11	Positron Emission Tomography (PET) and Mammography (PEM) for Breast Cancer: Importance to Surgeons 2006 ·Annals of Surgical Oncology ·Lorraine Tafra	18
12	Surgery: our challenges, our future 2005 ·The American Journal of Surgery ·Lorraine Tafra	1
13	Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis 2005 ·Journal of Molecular Diagnostics ·(unknown), Todd S. Laughlin, Yixin Wang, R. T. Belly, Robert J. White, (unknown), (unknown), (unknown), Lorraine Tafra, David Atkins, Kathryn M. Verbanac	40
14	Pilot trial of cryoprobe-assisted breast-conserving surgery for small ultrasound-visible cancers 2004 ·Breast Diseases A Year Book Quarterly ·Lorraine Tafra, (unknown), (unknown), (unknown)	1
15	Comparison of Intradermal and Subcutaneous Injections in Lymphatic Mapping 2001 ·Journal of Surgical Research ·(unknown), (unknown), Donald R. Lannin, (unknown), Lorraine Tafra	30
16	State-of-the-art lymph node staging for breast cancer in the year 2000 2000 ·The American Journal of Surgery ·Pat W. Whitworth, Kelly M. McMasters, Lorraine Tafra, Michael J. Edwards	12
17	The details of successful sentinel lymph node staging for breast cancer 2000 ·The American Journal of Surgery ·Michael J. Edwards, Pat W. Whitworth, Lorraine Tafra, Kelly M. McMasters	23
18	Fine-needle aspiration cytology of metastatic squamous-cell carcinoma arising in a pilonidal sinus, with literature review 1999 ·Diagnostic Cytopathology ·(unknown), Jan F. Silverman, Lorraine Tafra	11
19	EFFECTS OF COTRANSPLANTED FETAL LIVER ON FETAL PANCREAS ISOGRAFTS 1, 2. 1992 ·Transplantation ·Xuegong Wang, Lorraine Tafra, (unknown), Ricardo V. Lloyd, (unknown), Donald C. Dafoe	13
20	Studies of Composite Grafts of Fetal Pancreas (FP) and Fetal Liver (FL) in the Streptozotocin-Induced Diabetic Rat 1992 ·Advances in experimental medicine and biology ·Donald C. Dafoe, Xuegong Wang, Lorraine Tafra, (unknown), Ricardo V. Lloyd	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact